MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Neurology, Psychology, Mental Health, CNS, Pain & TBI Companies _ Alzheimers & Dementia
Neurotrack
Organization & Developments: Neurotrack
Parents
Neurotrack
Children
2012: Neurotrack was accepted into Rock Health’s Boston class in the summer of 2012, and won “Best Company” in the SXSW Digital Health competition.
An NIH-sponsored longitudinal study demonstrated that the test may help predict the cognitive decline associated with Alzheimer’s disease three to six years before symptom onset.
Neurotrack holds an exclusive license for the technology behind its innovative behavioral test from Emory University
Neurotrack is developing a cognitive test that can detect the first neurological effects of Alzheimer’s, up to six years before the onset of behavioral symptoms.
The results of the NIH-sponsored longitudinal study that support Neurotrack’s diagnostic were published earlier this year in the American Journal of Alzheimer’s Disease and Other Dementias (Zola, Manzanares et al., “A Behavioral Task Predicts Conversion to
Jumps
*Key People: Neurotrack
Finance & Acquisitions: Neurotrack